Drawing for ADROIQ

USPTO serial 90813452

ADROIQ

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
LOBO, DEBORAH E
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ADROIQ?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

PRESTON SMIRMAN

PRESTON SMIRMAN SMIRMAN IP LAW, PLLC116 TERRY AVENUEROCHESTER, MI 48307United States

Goods and services

ClassDescriptionStatusFirst use
005Anti-epileptic pharmaceutical preparations; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for the treatment of kidney diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 4, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 4, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 25, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 24, 2025EX5GSOU EXTENSION 5 GRANTED—
Dec 26, 2024EXT5SOU EXTENSION 5 FILED—
Dec 26, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 27, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 27, 2024EX4GSOU EXTENSION 4 GRANTED—
Jun 27, 2024EXT4SOU EXTENSION 4 FILED—
Jun 27, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 13, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 10, 2024EX3GSOU EXTENSION 3 GRANTED—
Jun 10, 2024AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 14, 2024NREVNOTICE OF REVIVAL - E-MAILED—
Feb 14, 2024PETGPETITION TO REVIVE-GRANTED—
Feb 14, 2024PROATEAS PETITION TO REVIVE RECEIVED—
Jan 29, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 29, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 28, 2023EXT3SOU EXTENSION 3 FILED—
Jun 28, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 26, 2023EX2GSOU EXTENSION 2 GRANTED—
Jun 26, 2023EXT2SOU EXTENSION 2 FILED—
Jun 26, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 28, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 26, 2022EX1GSOU EXTENSION 1 GRANTED—
Dec 26, 2022EXT1SOU EXTENSION 1 FILED—
Dec 26, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 28, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 3, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 3, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 13, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 28, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 28, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Mar 28, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 28, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 28, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 24, 2022DOCKASSIGNED TO EXAMINER—
Sep 15, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 10, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 10, 2021ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jul 10, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 10, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 9, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance